Relationships between serum procalcitonin level, severity and different stresses of non-septic critically ill patients

1. Avrillon V, Locatelli-Sanchez M, Folliet L, Carbon-naux M, Perino E, Fossard G, et al. Lung cancer may increase serum procalcitonin level. Infect Disord Drug Targets. 2015;15(1):57-63. DOI: 10.2174/1871526515 666150320162950Search in Google Scholar

2. Kaczka K, Mikosiński S, Fendler W, Celnik A, Pomorski L. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Adv Clin Exp Med. 2012;21(2):169-78.Search in Google Scholar

3. Rami D, La Bianca M, Agostinis C, Zauli G, Radillo O, Bulla R. The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. Mediators Inflamm. 2014;2014:248963. DOI: 10.1155/2014/24896310.1155/2014/248963Search in Google Scholar

4. Fung AWS, Beriault D, Diamandis EP, Burnham CD, Dorman T, Downing M, et al. The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges. Clin Chem. 2017;63(9):1436-41. DOI: 10.1373/clinchem.2017.27229410.1373/clinchem.2017.272294Search in Google Scholar

5. Schuetz P, Bretscher C, Bernasconi L, Mueller B. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Rev Mol Diagn. 2017;17(6):593-601. DOI: 10.1080/14737159.2017.132429910.1080/14737159.2017.1324299Search in Google Scholar

6. Jiang L, Feng B, Gao D, Zhang Y. Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis. J Int Med Res. 2015;43(2):188-95. DOI: 10.1177/030006051456113610.1177/0300060514561136Search in Google Scholar

7. Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, et al. Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes. 2014;7(1):458. DOI: 10.1186/1756-0500-7-45810.1186/1756-0500-7-458Search in Google Scholar

8. Anand D, Das S, Bhargava S, Srivastava LM, Garg A, Tyagi N, et al. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J Crit Care. 2015;30(1):218.e7-12. DOI: 10.1016/j. jcrc.2014.08.017Search in Google Scholar

9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med. 2013;41(2):580-637. DOI: 10.1097/CCM.0b013e31827e83af10.1097/CCM.0b013e31827e83afSearch in Google Scholar

10. Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95-107. DOI: 10.1016/S1473-3099(17)30592-310.1016/S1473-3099(17)30592-3Search in Google Scholar

11. Quach S, Hennessy DA, Faris P, Fong A, Quan H, Doig C. A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res. 2009;9:129-36. DOI: 10.1186/1472-6963-9-12910.1186/1472-6963-9-129273174419643010Search in Google Scholar

12. Yang CJ, Chen J, Phillips AR, Windsor JA, Petrov MS. Predictors of severe and critical acute pancreatitis: a systematic review. Dig Liver Dis. 2014;46(5):446-51. DOI: 10.1016/j.dld.2014.01.15810.1016/j.dld.2014.01.15824646880Search in Google Scholar

13. Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci. 2015;52(6):273-83. DOI: 10.3109/10408363.2015.105165910.3109/10408363.2015.105165926173077Search in Google Scholar

14. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targe. Br J Pharmacol. 2010;159(2):253-64. DOI: 10.1111/j.1476-5381.2009.00433.x10.1111/j.1476-5381.2009.00433.x282534920002097Search in Google Scholar

15. Ryu JA, Yang JH, Lee D, Park CM, Suh GY, Jeon K, et al. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock. PLoS One. 2015;10(9):e0138150. DOI: 10.1371/journal. pone.0138150Search in Google Scholar

16. Trásy D, Molnár Z. Procalcitonin - Assisted Antibiotic Strategy in Sepsis. EJIFCC. 2017;28(2):104-13.Search in Google Scholar

17. Zhao JJ, Lou XL, Chen HW, Zhu FT, Hou YQ. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis. Cell Mol Biol Lett. 2018;23:22-31. DOI: 10.1186/s11658-018-0087-z10.1186/s11658-018-0087-z594162129760745Search in Google Scholar

18. Tuzun A, Uygun A, Yesilova Z, Ozel AM, Erdil A, Yaman H, et al. Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol. 2004;19(4):429-32. DOI: 10.1111/j.1440-1746.2003.03300.x10.1111/j.1440-1746.2003.03300.x15012781Search in Google Scholar

19. Chooklin S, Hranat O. Intraarterial therapy, interleukins and oxidative stress parameters in acute pancreatitis patients. Pancreatology. 2013;13(2):e20. DOI: 10.1016/j. pan.2012.12.124Search in Google Scholar

20. Liu HH, Guo JB, Geng Y, Su L. Procalcitonin: present and future. Ir J Med Sci. 2015;184(3):597-605. DOI: 10.1007/s11845-015-1327-010.1007/s11845-015-1327-026159431Search in Google Scholar

21. Huang HL, Nie X, Cai B, Tang JT, He Y, Miao Q, et al. Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study. PLoS One. 2013;8(12):e82250. DOI: 10.1371/journal. pone.0082250Search in Google Scholar

22. Wu JY, Lee SH, Shen CJ, Hsieh YC, Yo PH, Cheng HY, et al. Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis. Arthritis Rheum. 2014;64(9):3034-42. DOI: 10.1002/art.3451210.1002/art.3451222605405Search in Google Scholar